In their cohort study, Lin et al. pointed out a lower risk of congenital malformations in women with pre-existing T2DM treated with metformin compared with those treated with insulin (OR 0.51, 95% CI 0.27 to 0.94; p = 0.032). This evidence concerns the gene INS and type 2 diabetes mellitus.